Scarica l'app Stockscreener
0.6082
2.58%
-0.0161
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER - GlobeNewswire
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) DEADLINE ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Vistagen Therapeutics, Inc. Stockholders with Large Losses in VTGN Should Contact Robbins LLP for Information About Leading the Vistagen Therapeutics, Inc. Securities Class Action Lawsuit - The AI Journal
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Vistagen - GlobeNewswire
2026-01-26 | VTGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:VTGN | Press Release - Stockhouse
VISTAGEN CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Notifies Vistagen (VTGN) Investors of the Pending Class Action Lawsuit - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionVTGN - TMX Newsfile
CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Vistagen - GlobeNewswire
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit - Barchart.com
ROSEN, A LEADING LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionVTGN - marketscreener.com
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) DEADLINE ALERT – - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics - Barchart.com
Portnoy Law Firm Announces Class Action on Behalf of Vistagen Therapeutics, Inc. Investors - GlobeNewswire
Vistagen Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Vistagen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 16, 2026VTGN - Barchart.com
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics - marketscreener.com
Vistagen Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
VTGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - GuruFocus
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen - GlobeNewswire
Vistagen (VTGN) Stock Plummets 80% After Phase 3 Trial Failure - Intellectia AI
VISTAGEN ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire
VTGN Investors Encouraged to Seek Lead Plaintiff Role in - GlobeNewswire
Buybacks Report: What is the next catalyst for Vistagen Therapeutics IncTrade Performance Summary & Stock Market Timing Techniques - baoquankhu1.vn
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (NASDAQ:VTGN) - ACCESS Newswire
Analyst Upgrade: Is Vistagen Therapeutics Inc attractive for institutional investorsJuly 2025 Volume & Long Hold Capital Preservation Tips - baoquankhu1.vn
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionVTGN - ACCESS Newswire
Vistagen Therapeutics Faces Class Action Lawsuit for Securities Fraud - Intellectia AI
Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - PR Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionVTGN - TMX Newsfile
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-01-19 | VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:VTGN | Press Release - Stockhouse
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, I - GuruFocus
Vistagen Therapeutics Faces Class Action Lawsuit; Investors Encouraged to Claim Losses - Intellectia AI
VTGN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionVTGN - TMX Newsfile
Faruqi & Faruqi Investigates Vistagen Investors' Claims Ahead of March 2026 Deadline - Intellectia AI
SHAREHOLDER ACTION NOTICE: Faruqi & Faruqi, LLP Notifies Vistage - GuruFocus
SHAREHOLDER ACTION NOTICE: Faruqi & Faruqi, LLP Notifies Vistagen (VTGN) Investors of the Pending Class Action Lawsuit - PR Newswire
2026-01-18 | VTGN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:VTGN | Press Release - Stockhouse
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages - GlobeNewswire
Short Interest in VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Rises By 88.9% - Defense World
VTGN Stockholder Alert: Robbins LLP Reminds Investors of the Cla - GuruFocus
Vistagen Therapeutics (VTGN) Faces Class Action Over Misleading Trial Results, Stock Plummets 80% - Intellectia AI
VTGN Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Vistagen Therapeutics, Inc. - PR Newswire
Vistagen Therapeutics Faces Class Action Lawsuit, Shareholders May Claim Compensation - Intellectia AI
Vistagen Therapeutics Faces Class Action Lawsuit for Misleading Investors on Drug Development - Intellectia AI
VTGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Rosen Law Firm Urges Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) INVESTOR ALERT - GlobeNewswire
About Us - FinancialContent
Vistagen Therapeutics Faces Class Action for Securities Fraud, Investors Can Claim Losses - Intellectia AI
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):